MATERION CORPORATION (MTRN): what the price requires
At today's price, MATERION CORPORATION (MTRN) is priced for today's economics sustained for ~12.4 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/MTRN
Headline
| Field | Value |
|---|---|
| Ticker | MTRN |
| Company | MATERION CORPORATION |
| Current price | $246.34/sh |
| Composition | Semiconductor 49% / Industrial 11% / Aerospace and Defense 12% / Consumer Electronics 9% / Automotive 4% / Energy 7% / Life Sciences 3% / Other 5% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 14.6% |
| Operating margin today | 6.9% |
| Margin expansion implied | +7.7pp |
| Must persist for | 12.4y |
| Multiple paid | 45x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 10.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.2 years.
Reconcile: at the x-ray's 9.3% required return this reads ~9 years; the models below use their own rates.
How unusual the bet is: high
| Reference | Value |
|---|---|
| vs own history | +0.10σ |
| cohort percentile (of 225 peers) | 87 |
| sustained it ~10 years at this level | 14% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 6.50x | 4 | expensive |
| Earnings | 6.24x | 3 | expensive |
| Relative | 1.88x | 5 | expensive |
| Growth | 1.10x | 3 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.4%); the inversion above states its own rate.
Per-Model Detail (n=15)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $69.37 | 3.55x | yes | FCF base $0.1B, growth 12% (input: historical growth), terminal g 4.0%, WACC 8.4%, 6yr projection |
| DCF Exit Multiple | Growth | $249.94 | 0.99x | yes | Exit EV/EBITDA: 29.5x / 31.5x / 33.5x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $130.76 | 1.88x | yes | P/E 32.9x (blended: static sector reference 18x + trailing (TTM) 68x), scenarios: 27.2x / 32.9x / 38.6x (bear / base = reference held flat / bull), EV/EBITDA 17.86x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $39.37 | 6.26x | yes | BV/sh $45.55, ROE (TTM) 8.0%, ke 9.3% |
| Two-Stage Excess Return | Asset | $36.55 | 6.74x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $224.89 | 1.10x | yes | Rev $1.9B, growth 12% (input: historical growth; tapered), Terminal P/S: 2.2x / 2.7x / 3.2x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $127.75 | 1.93x | yes | EPS $3.65, growth 35% (input: historical EPS growth), PEG=1.93 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $33.22 | 7.42x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.11B × (1−7%) / WACC 8.4% → EPV (no growth) |
| Residual Income | Asset | $36.11 | 6.82x | yes | BV $45.55 + 5yr PV of (ROE (TTM) 8.0% − Kₑ 9.3%) × BV; BV grows 5.2%/yr |
| Graham Number | Asset | $61.17 | 4.03x | yes | √(22.5 × EPS $3.65 × BVPS $45.55) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $77.25 | 3.19x | yes | EBITDA $0.18B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $8.50 | 28.98x | yes | FCF $68.1M / Kₑ 9.3% — zero-growth perpetuity (excluded from median) |
| SBC-Adj FCF Yield | Earnings | $2.53 | 97.37x | yes | SBC-adj FCF $0.06B (FCF $0.07B − SBC $0.01B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $117.77 | 2.09x | yes | EPS $3.65 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $9.29 | 26.52x | yes | BV $45.55 × (ROIC 1.7% / WACC 8.4%) (excluded from median) |
| P/Sales Sector | Relative | $228.02 | 1.08x | yes | Revenue $1.92B × sector P/S 2.5x |
| PEG Fair Value | Relative | $136.88 | 1.80x | yes | EPS $3.65 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $39.46 | 6.24x | yes | EPS $3.65 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $512.1m |
| Net debt / NOPAT (after-tax) | 4.35x |
| Net debt / operating income (pre-tax) | 4.03x |
| Interest coverage | 4.2x |
| Share count CAGR (dilution) | 0.3% |
| Burning cash | no |
Bullet Takeaways
- Materion makes specialty engineered materials, beryllium alloys, precision optics, and advanced coatings, for semiconductors, defense, and aerospace, niches where its precision cladding and plating capabilities are hard to substitute.
- The biggest risk is the price: at roughly 50x operating income it embeds many years of near-ceiling growth, a demanding bet that only the growth-DCF method supports while every static lens calls the stock richly valued.
- Watch the order book, where aerospace-and-defense orders are up about 50% and high-performance memory sales up 47%, the demand signal that has to convert into the value-added margin the price requires.
Bull Case
What the static valuation methods cannot capture about Materion is that its trailing earnings understate the business, while its order book points to acceleration. Materion makes advanced engineered materials for the most demanding end markets, semiconductors, defense, aerospace, and energy, where the 10-K describes specialized "precision cladding and plating capabilities" that impart specific electrical, mechanical, or optical properties to a material's surface. These are not commodity inputs; they are engineered to a customer's spec, often designed into a defense platform or a chip-fabrication process where switching suppliers means requalification. That is a real moat, and it is why the company can earn premium margins on the part of its business that matters.
The right way to read Materion's growth is on a value-added basis, which strips out the volatile metal costs that pass straight through to customers. On that basis, the order acceleration is striking: aerospace and defense orders are up roughly 50% year over year, energy up 20%, and semiconductor up 10%, with high-performance memory and data-storage sales up 47%. Value-added gross margin expanded to 31% from 29% on better mix and manufacturing efficiency. When orders across the highest-value end markets are growing at double-digit-to-50% rates and margins are widening, the business is inflecting, even if the headline trailing earnings still look modest.
The end-market tailwinds are secular, not cyclical noise. Defense budgets are rising, semiconductor content is expanding into AI and high-performance memory, and space and energy applications all demand the specialized materials Materion supplies. Management's 2026 guidance calls for around 15% earnings growth with margin expansion and improved free cash flow. The bull case is a specialty-materials franchise with a hard-to-replicate process moat, an accelerating order book across structurally growing end markets, and trailing earnings that understate where the business is heading.
Bear Case
The bear case is clearest in how violently the valuation methods disagree, and which ones deserve the benefit of the doubt. Strip the methods into families and the verdict is lopsided: the asset-value lens reads the stock at roughly seven times where book value and returns justify, the earnings-power lens reads it at nearly eight times normalized profit, and the peer-multiple lens reads it at about twice the sector multiple. Only the growth-DCF reaches the price, and it gets there by holding today's roughly 35x exit EBITDA multiple flat for the life of the forecast. When eleven of the methods say richly valued and only the one that extrapolates growth reaches the price, the honest read is that the conservative lenses are probably right and the stock is pricing an outcome that has to go perfectly.
The scale of that bet is the problem. At about 50x operating income, the price embeds growth held near its self-funding ceiling for roughly fourteen years, a persistence only about 14% of comparable fast-growers have historically achieved. The trailing operating margin is just 5.8%, depressed in part because metal pass-through inflates the revenue base, and the price requires that margin to roughly triple toward 16% and hold. That is a long, narrow path. The trailing P/E sits near 76x, and even after a strong quarter the KeyBanc analyst's raised price target of $223 sits below the current price, a rare case where the bull-rated analyst's target undercuts where the stock trades.
The cyclicality the price ignores is real and disclosed. The 10-K warns that demand from many of Materion's customers is "subject to significant fluctuations as a result of the cyclical nature of their industries and their sensitivity to general economic conditions", and the same filing notes that prices for the precious and specialty metals it uses "have fluctuated significantly in recent years" amid geopolitical instability. Semiconductor and defense end markets, the growth engine, are themselves cyclical and politically exposed; China was a notable drag on semiconductor sales even in a strong quarter. Net debt of about $512 million with interest covered only 3.5 times leaves a thin cushion for a company whose earnings are this sensitive to the cycle. The bet is flawless multi-year execution priced at a multiple that punishes any stumble.
Valuation
At $275.56 (June 27, 2026), Materion's price makes one of the more demanding bets in this group. Inverted, it implies operating growth held near the self-funding ceiling for roughly fourteen years, an assumption the framework labels elevated, and one only about 14% of comparable fast-growers have historically sustained over a decade. Compounding the demand, the trailing operating margin is just 5.8%, depressed partly because rising metal prices pass through and inflate the net-sales denominator. The price effectively requires that margin to expand sharply, toward the mid-teens, and to hold there.
The disagreement among the methods is the sharpest signal here. The asset-value family lands far below the price, with Simple Excess Return near $39 against a book value of about $46 and a trailing return on equity of just 8%. The earnings-power family is lower still, with Earnings Power Value near $33 on five-year-average normalized operating income. The peer-multiple family lands near $77 to $140. Only the forward-growth family reaches the price, and only the exit-multiple DCF lands at it by holding today's ~35x EBITDA multiple flat. The pattern could not be clearer: every static lens calls the stock expensive, and the price survives solely on a durable-growth assumption the static methods structurally cannot frame. That is a moat-and-durability premium, and whether it is warranted depends entirely on the value-added franchise compounding for far longer than the methods will credit.
The peer cohort, industrial-machinery names like Woodward, Crane, and AAON, is a loose comparison, because none is a clean comp for a beryllium-and-specialty-materials maker; the right lens is the company's own value-added economics rather than a sector multiple. Reading the business on a value-added basis matters: net sales rose 31% last quarter, but value-added sales rose only 1%, with the difference being metal pass-through that carries no margin. Solvency is adequate but not generous: net debt near $512 million with interest covered 3.5 times. The decisive variable is margin: whether the accelerating, high-value defense, semiconductor, and aerospace orders lift the value-added margin enough, for long enough, to grow into a price the conservative methods call rich by a wide margin.
Catalysts
The first-quarter 2026 results, reported April 29, were strong on the metrics that matter. Net sales rose 31% to $549.8 million, though most of that came from higher precious-metal pass-through pricing; on a value-added basis, which strips out metal costs, sales were $261.8 million, up 1%. Net income rose to $19.4 million and diluted EPS to $0.92, helped by better mix and manufacturing efficiency, and value-added gross margin expanded to 31% from 29%.
The forward signal is the order book, and it is accelerating across the highest-value end markets. Aerospace and defense orders are up roughly 50% year over year, energy up 20%, and semiconductor up 10%, with semiconductor sales up 16%, or 40% excluding China, and high-performance memory and data-storage sales up 47%. For a specialty-materials maker, order growth at these rates across defense and advanced computing is the clearest leading indicator of the value-added margin expansion the thesis depends on. Management's 2026 guidance calls for about 15% earnings growth with margin expansion and improved free cash flow.
Analyst sentiment turned more positive on the quarter, with KeyBanc raising its price target to $223 from $185 and keeping an Overweight rating, though notably that target still sits below the current price. The next quarterly print is the test of whether the order acceleration converts to recognized value-added revenue and whether the margin path tracks toward what the elevated price requires.
Peer Cohorts (Per Segment, With Filing Citations)
Performance Materials (reported)
- CRS (CARPENTER TECHNOLOGY CORPORATION)
- (no filing in the citation store)
- ATI (ATI INC)
- (no filing in the citation store)
- WS (WORTHINGTON STEEL, INC.)
- (no filing in the citation store)
Electronic Materials (reported)
- ENTG (Entegris, Inc.)
- (no filing in the citation store)
- ESI (Element Solutions Inc)
- (no filing in the citation store)
- ROG (Rogers Corporation)
- (no filing in the citation store)
- CBT (Cabot Corporation)
- (no filing in the citation store)
Precision Optics (reported)
- COHR (COHERENT CORP.)
- (no filing in the citation store)
- LITE (Lumentum Holdings Inc.)
- (no filing in the citation store)
- FN (FABRINET)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
MTRN FY2025 10-K · Materion Q1 2026 results, April 29, 2026 · KeyBanc, 2026